Volume 22, Number 9—September 2016
CME ACTIVITY - Synopsis
Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa
Figure 1

Figure 1. Kaplan–Meier survival curves of 2-year survival probability (product limit survival estimates) for patients with extensively drug-resistant tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa, 2006–2010. Group 0, HIV-negative patients; group 1, HIV-positive patients receiving antiretroviral drugs at start of treatment; group 2: HIV-positive patients not receiving antiretroviral drugs at start of treatment. +, censored value.
Page created: August 11, 2016
Page updated: August 11, 2016
Page reviewed: August 11, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.